Skip to main content
. 2022 Mar 14;45(2):e275–e284. doi: 10.1093/pubmed/fdac032

Table 4.

Psychological outcomes in the negative test (−ve) and CGs (no test) from 1 to 12 months

1m 3m 6m 12m
−ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] −ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] −ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] −ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] P-value diff. between groups over time
PANAS positive 31.82 (8.19) 30.61 (8.50) 1.52 [0.43, 2.61] 30.91 (8.29) 30.00 (8.39) 1.43 [0.33, 2.53] 31.10 (8.40) 30.15 (9.25) 1.27 [0.17, 2.37] 30.90 (8.27) 30.43 (9.49) 1.03 [−0.09, 2.14] 0.80
PANAS negative 16.36 (7.45) 16.94 (7.53) 15.94 (6.94) 17.29 (7.83) 16.55 (7.33) 17.03 (8.00) 16.54 (7.01) 16.97 (8.10)
PANAS negative (log) 2.71 (0.38) 2.75 (0.39) −0.05 [−0.11, 0.01] 2.69 (0.37) 2.76 (0.40) −0.08 [−0.13, −0.02] 2.73 (0.38) 2.75 (0.40) −0.02 [−0.08, 0.04] 2.73 (0.38) 2.74 (0.41) −0.03 [−0.09, 0.03] 0.09
LCWS—impact 3.27 (1.62) 3.28 (1.63) −0.13 [−0.33, 0.07] 3.17 (1.62) 3.31 (1.60) −0.27 [−0.48, −0.07] 3.30 (1.69) 3.30 (1.64) −0.17 [−0.37, 0.04] 3.32 (1.77) 3.35 (1.60) −0.19 [−0.40, 0.01] 0.48
−ve test, N (%) No test, N (%) OR [95% CI] −ve test, N (%) No test, N (%) OR [95% CI] −ve test, N (%) No test, N (%) OR [95% CI] −ve test, N (%) No test, N (%) OR [95% CI]
LCWS—frequency 201 (57.59) 214 (62.76) 0.66 [0.35, 1.23] 185 (55.72) 207 (62.35) 0.49 [0.26, 0.92] 181 (56.39) 204 (62.01) 0.56 [0.29, 1.07] 178 (56.87) 196 (61.64) 0.59 [0.31, 1.14] 0.86
LCWS—worry 47 (13.51) 52 (15.25) 0.63 [0.28, 1.39] 53 (16.01) 56 (16.92) 0.69 [0.32, 1.51] 60 (18.69) 57 (17.48) 0.92 [0.43, 1.98] 63 (20.32) 68 (21.52) 0.65 [0.31, 1.37] 0.80

Adjusted for study site (Greater Glasgow and Clyde, Tayside), minimization variables (age group, gender and smoking history) and baseline values where measured. M = mean. 1m = 1 month, 3m = 3 months, 6m = 6 months, 12m = 12 months